VANCOUVER, British Columbia, March 04, 2021 (GLOBE NEWSWIRE)
Global Care Capital Inc. (CSE:
HLTH, FRANKFURT
Company” or “
Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies is pleased to announce that its 100% owned portfolio company, HealthView Technologies Inc. (“
HealthView”) has begun to generate revenue and has achieved its second of two earn-out milestones in accordance with the terms of the definitive agreement that was entered in connection with the acquisition of HealthView by the Company (the “
Transaction”).
As of February 28
th, 2021, HealthView achieved its second and final of two earn-out milestones by generating revenue. As a result, the Company will issue 10,000,000 common shares, (the “
VANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE)
Global Care Capital Inc. (CSE:
HLTH, FRANKFURT
Company” or “
Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that further to its press release of January 21, 2021 it has now completed the acquisition of all of the issued and outstanding securities in the capital of ASIC Power Corporation (“
ASIC”) pursuant to the terms of a share exchange agreement dated January 19, 2021 (the “
Agreement”) among the Company, ASIC and the shareholders of ASIC (the “
Transaction”). ASIC is the first cryptocurrency company combining state of the art ASIC chips with royalty streaming contracts.
DISSEMINATION IN THE UNITED STATES
VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE)
Global Care Capital Inc. (CSE:
HLTH, FRANKFURT
Company” or “
Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that further to its press release of December 30, 2020 it has entered into a share exchange agreement dated January 19, 2021 (the “
Agreement”) between the Company, ASIC Power Corporation (“
ASIC”) and the shareholders of ASIC which sets out the terms and conditions for the acquisition by the Company of all of the issued and outstanding securities in the capital of ASIC (the “
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the
Company ,
Hollister Cannabis Co. or
Hollister ) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 90 dispensaries throughout Arizona, is pleased to provide an update on its Q4, 2020 performance.
Q4 2020 Update
st, 2020 and ending December 31
st, 2020, Hollister reports that it generated record quarterly revenue of CDN$14.93 million and CDN$2.53 million in EBITDA from its product line of pre-rolls, concentrates, distillates, solvent-free bubble hash, pre-packaged flower, tinctures and vape products. The Company cautions that revenue and EBITDA figures have not yet been audited and are based on reports prepared by management.
In the news release, Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019, issued 07-Jan-2021 by Hollister Biosciences Inc. over CNW, we are advised by the company that the title should read “CDN $2.53 Million in EBITDA ” rather than “CDN $5.53 Million in EBITDA” as … In the news release, Hollister Biosciences Inc. Provides Update on Q4 2020 Performance Including CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019, issued 07-Jan-2021 by Hollister Biosciences Inc. over CNW, we are advised by the company that the title should read “CDN $2.53 Million in EBITDA ” rather than “CDN $5.53 Million in EBITDA” as originally issued inadvertently. The complete, corrected release follows: